 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trinity Biotech reveals Q4 results and strategic initiatives amidst a challenging fiscal year, setting the stage for a transformative 2024.Related Stocks: TRIB...

Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...

Q4 2023 Trinity Biotech PLC Earnings Call Transcript

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics...

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript...

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Investment analysts at StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB - Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a...

Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com

Trinity Biotech plc (NASDAQ:TRIB  Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling...

Trinity Biotech plc (NASDAQ:TRIB) Short Interest Update

Conference Call Scheduled for Thursday, April 4, 2024 at 8:00 AM ETDUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the Company ), a leading developer and...

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB  Free Report) in a research report released on Friday. The brokerage issued a buy rating on the stock.
Trinity Biotech...

StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB  Free Report) in a report released on Thursday. The brokerage issued a buy rating on the stock.
Trinity Biotech Stock...

StockNews.com Begins Coverage on Trinity Biotech (NASDAQ:TRIB)

DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the Company ) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC...

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Volume (M)	5,746.00
52-Wk High	$5.50
52-Wk Low	$1.79

TRIB Trinity Biotech plc

About

Feed

News

Fundamentals